Ledaga (chlormethine hydrochloride)

pCPA File Number: 21677
Negotiation Status:
Under consideration for negotiation
Indication(s):
For the topical treatment of stage IA and IB mycosis fungoidestype cutaneous Tcell Lymphoma (MF-CTCL) in adult patients who have received prior skindirected therapy
Sponsor/Manufacturer:
Recordati Rare Diseases Canada Inc.
CADTH Project Number:
PC0242
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable